FindTrial
Sign In

A registered study: the treatment of hyperthyroidism and its associated liver injury in Chinese adults

A registered study: the treatment of hyperthyroidism and its associated liver injury in Chinese adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062950
Enrollment
Unknown
Registered
2022-08-25
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism and associated liver injury

Interventions

None:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.It meets the diagnostic criteria of hyperthyroidism formulated by authoritative organizations such as the American Thyroid Association (ATA) in 2016, the European Thyroid Association (ETA) in 2018 or the endocrinology branch of the Chinese Medical Association; 2.Age >= 18 years old; 3.Willing to sign informed consent for research

Exclusion criteria

Exclusion criteria: 1.Unwilling to sign informed consent; 2.The researchers believe that there are any circumstances that are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
height;weight;Body temperature;Heart rate;breathing;Blood pressure;Thyroid function and antibody tests;Liver function;renal function;Electrocardiogram examination;Thyroid imaging examination;Liver imaging examination;—

Countries

china

Contacts

Public ContactTongNanwei

West China Hospital, Sichuan University

tongnanwei@aliyun.com18980601196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026